Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A genome-wide haploid genetic screen identifies heparan sulfate-associated genes and the macropinocytosis modulator TMED10 as factors supporting vaccinia virus infection.

Luteijn RD, van Diemen F, Blomen VA, Boer IGJ, Manikam Sadasivam S, van Kuppevelt TH, Drexler I, Brummelkamp TR, Lebbink RJ, Wiertz EJ.

J Virol. 2019 Apr 17. pii: JVI.02160-18. doi: 10.1128/JVI.02160-18. [Epub ahead of print]

PMID:
30996093
2.

EBV MicroRNA BART16 Suppresses Type I IFN Signaling.

Hooykaas MJG, van Gent M, Soppe JA, Kruse E, Boer IGJ, van Leenen D, Groot Koerkamp MJA, Holstege FCP, Ressing ME, Wiertz EJHJ, Lebbink RJ.

J Immunol. 2017 May 15;198(10):4062-4073. doi: 10.4049/jimmunol.1501605. Epub 2017 Apr 17.

3.

Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion.

van Gent M, Gram AM, Boer IG, Geerdink RJ, Lindenbergh MF, Lebbink RJ, Wiertz EJ, Ressing ME.

J Gen Virol. 2015 Apr;96(Pt 4):858-65. doi: 10.1099/jgv.0.000021. Epub 2014 Dec 12.

PMID:
25502648
4.

Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.

van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME.

PLoS Pathog. 2014 Feb 20;10(2):e1003960. doi: 10.1371/journal.ppat.1003960. eCollection 2014 Feb.

5.

Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus.

Boer JC, Domanska UM, Timmer-Bosscha H, Boer IG, de Haas CJ, Joseph JV, Kruyt FA, de Vries EG, den Dunnen WF, van Strijp JA, Walenkamp AM.

Br J Cancer. 2013 Feb 19;108(3):587-96. doi: 10.1038/bjc.2012.603. Epub 2013 Jan 15.

6.

The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Horst D, Burmeister WP, Boer IG, van Leeuwen D, Buisson M, Gorbalenya AE, Wiertz EJ, Ressing ME.

J Virol. 2012 Sep;86(17):9175-87. doi: 10.1128/JVI.00309-12. Epub 2012 Jun 13.

7.

Evaluation of a website providing information on regional health care services for patients with rheumatoid arthritis: an observational study.

Meesters JJ, de Boer IG, van den Berg MH, Fiocco M, Vliet Vlieland TP.

Clin Rheumatol. 2012 Apr;31(4):637-45. doi: 10.1007/s10067-011-1897-9. Epub 2011 Dec 13.

8.

Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.

Horst D, Burrows SR, Gatherer D, van Wilgenburg B, Bell MJ, Boer IG, Ressing ME, Wiertz EJ.

J Virol. 2012 Jan;86(1):572-7. doi: 10.1128/JVI.05151-11. Epub 2011 Oct 19.

9.

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME.

J Immunol. 2011 Feb 1;186(3):1694-702. doi: 10.4049/jimmunol.0903120. Epub 2010 Dec 29.

10.

Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and platelets.

Walenkamp AM, Bestebroer J, Boer IG, Kruizinga R, Verheul HM, van Strijp JA, de Haas CJ.

Cell Oncol. 2010;32(1-2):1-10. doi: 10.3233/CLO-2009-0486.

11.

Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.

Walenkamp AM, Boer IG, Bestebroer J, Rozeveld D, Timmer-Bosscha H, Hemrika W, van Strijp JA, de Haas CJ.

Neoplasia. 2009 Apr;11(4):333-44.

12.

Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins.

Bestebroer J, van Kessel KP, Azouagh H, Walenkamp AM, Boer IG, Romijn RA, van Strijp JA, de Haas CJ.

Blood. 2009 Jan 8;113(2):328-37. doi: 10.1182/blood-2008-04-153882. Epub 2008 Oct 21.

13.

Assistive devices: usage in patients with rheumatoid arthritis.

de Boer IG, Peeters AJ, Ronday HK, Mertens BJ, Huizinga TW, Vliet Vlieland TP.

Clin Rheumatol. 2009 Feb;28(2):119-28. doi: 10.1007/s10067-008-0989-7. Epub 2008 Aug 26.

PMID:
18726549
14.

The usage of functional wrist orthoses in patients with rheumatoid arthritis.

de Boer IG, Peeters AJ, Ronday HK, Mertens BJ, Breedveld FC, Vliet Vlieland TP.

Disabil Rehabil. 2008;30(4):286-95.

PMID:
17852215
15.

Are patients with rheumatoid arthritis less physically active than the general population?

van den Berg MH, de Boer IG, le Cessie S, Breedveld FC, Vliet Vlieland TP.

J Clin Rheumatol. 2007 Aug;13(4):181-6.

PMID:
17762450
16.

Most people with rheumatoid arthritis undertake leisure-time physical activity in the Netherlands: an observational study.

van den Berg MH, de Boer IG, le Cessie S, Breedveld FC, Vliet Vlieland TP.

Aust J Physiother. 2007;53(2):113-8.

17.

Re: Touch screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis.

de Boer IG, Vliet Vlieland TP.

Rheumatology (Oxford). 2006 Aug;45(8):1050-1; author reply 1052. Epub 2006 May 22. No abstract available.

PMID:
16717062

Supplemental Content

Support Center